Antivirals for influenza: historical perspectives and lessons learned.
about
The pathology of influenza virus infectionsThe role of viral, host, and secondary bacterial factors in influenza pathogenesisInfluenza viruses: breaking all the rulesA randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combinationSelf-interest versus group-interest in antiviral controlGene expression signature-based screening identifies new broadly effective influenza a antiviralsPandemic influenza: antiviral preparedness and health care workers.Understanding the within-host dynamics of influenza A virus: from theory to clinical implicationsMeeting report: risk assessment of tamiflu use under pandemic conditions.Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.Emerging antiviral targets for influenza A virus.Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice.Recent progress and challenges in the discovery of new neuraminidase inhibitors.Novel influenza virus NS1 antagonists block replication and restore innate immune function.Newer influenza antivirals, biotherapeutics and combinations.Developing new antiviral agents for influenza treatment: what does the future hold?Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.Consequences of non-intervention for infectious disease in African great apes.Comparison between pernasal flocked swabs and nasopharyngeal aspirates for detection of common respiratory viruses in samples from children.Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity.Influenza neuraminidase: a druggable target for natural products.RNA Viruses and RNAi: Quasispecies Implications for Viral EscapeInhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes.Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode.Maoto, a Traditional Japanese Herbal Medicine, Inhibits Uncoating of Influenza Virus.Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase.Performance evaluation of Puritan® universal transport system (UniTranz-RT™) for preservation and transport of clinical viruses.Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease.Study on the abuse of amantadine in tissues of broiler chickens by HPLC-MS/MS.
P2860
Q22255608-D5461D81-4A6A-469C-9F70-D9B8CEA0BB17Q28082144-3E0B14E5-4654-40FB-AFFC-A89121FD0913Q28386965-5CD8A13E-5168-416C-8FF3-19C498AC9129Q28471710-2D4A0CBD-B655-4856-B92A-DFF75493CAF7Q28474269-C9C13710-A3EB-4A18-81CC-DCEB0DD95649Q28475681-5ADF5E66-CC8D-4F1A-895B-9BEED976FC7DQ30227214-D6A0FE3F-787D-49EE-BC3F-53B72B4C470CQ30357678-F6F52729-BC66-414C-B117-154C59487972Q30373734-D18D10A6-621E-408B-A624-4ADA5CDB2B04Q30374227-FD6AD0AF-38A3-43AB-8B98-868FED51A29EQ30376907-EAFBDA96-AAB5-47AB-872F-85F5849BF340Q30389591-0BCE73E2-8BA9-4FE3-98CC-EC80E8A40AE2Q30391956-8C80DE95-EEF3-47BB-8686-3924016E1242Q30426630-4224D9AD-24BD-4058-8689-22BF3C845813Q30439074-C7297465-3EB8-41EA-A304-8981A827CB26Q30456363-ABE934F6-61CB-48DE-9F46-D92332925C17Q34015113-4CBFDADC-AE51-40C2-BBE5-73A3D1841DCCQ34058036-E3A07B9B-F951-42C8-9DEE-EA04CD10B825Q34117137-C24E3F3C-337C-4713-B251-FF2E585D6226Q36747656-D6F6AB27-5F72-441F-8DB0-7FFBE85E51D3Q37289325-A251ADA5-C50F-478D-8E47-2F74AE032425Q37949284-C48D5970-AF1B-4C3F-8A27-146A5EF30A8EQ38535397-2D2C78BA-1118-4033-B114-160913CB1646Q39579556-F7865E0C-BDFF-4374-BAA6-3F3FF18A19F1Q39765565-A7894780-7C92-42FF-98D8-C7419F3209D0Q40042197-FE4CB248-71A0-49B2-8B89-B1CC429C1BC2Q41169102-88664EA4-AD9D-4CBD-BDC9-1573DB562ED5Q41514212-D23C4EF1-DB71-4855-8A09-7CB6C924B4A7Q45323667-899FD61A-0E2E-4A8D-80E6-A223747D13E2Q50925652-D0F74802-CDAB-45FA-8045-CDD19CE2BEA1
P2860
Antivirals for influenza: historical perspectives and lessons learned.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antivirals for influenza: historical perspectives and lessons learned.
@ast
Antivirals for influenza: historical perspectives and lessons learned.
@en
type
label
Antivirals for influenza: historical perspectives and lessons learned.
@ast
Antivirals for influenza: historical perspectives and lessons learned.
@en
prefLabel
Antivirals for influenza: historical perspectives and lessons learned.
@ast
Antivirals for influenza: historical perspectives and lessons learned.
@en
P1433
P1476
Antivirals for influenza: historical perspectives and lessons learned.
@en
P304
P356
10.1016/J.ANTIVIRAL.2006.05.016
P577
2006-06-09T00:00:00Z